Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by toinv261on Apr 29, 2015 6:15pm

212 Views

Post# 23678273

RE:...funny how it goes...

kelsee....it's obvious I'm holding mine!

I have never seen such rapid, positive development and I could list out 20 to 30 points but many have been expressed by me and others in previous posts.

This is going to be a blockbuster! In spite of the current share price and the short term ups and downs the underlying long term trend is going to be nowhere but up (IMHO) and as Don builds these regional strategies, as he has demonstrated this week, his negotiating power with BP will continue to grow. If BP doesn't bite we may well see a new strategy evolved as Shenzhen Hepalink has achieved with Heparin Sodium API. The old stalwarts of BP are being challenged.

DYODD
Cheers
Toinv :)

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?